Alcidion Group Limited · ASX:ALC
Alcidion — Investor Presentation (February 2016)
38 slides from Alcidion's investor presentation, Feb 26, 2016
Slide 1: Investor Presentation announcement
26 February 2016 Australian Securities Exchange (ASX) For personal use only Level 40, Central Park 152-158 St Georges Terrace Perth WA 6000 INVESTOR PRESENTATION Alcidion Group Limited (Alcidion) (Company) (ASX: ALC) is pleased to confirm that the Company will be reinstated to official quotation fro
Slide 2: Alcidion Group Limited Investor Presentation February 2016
For personal use only Alcidion Group Limited Investor Presentation February 2016 1
Slide 3: Disclaimer
DISCLAIMER Disclaimer This presentation has been prepared by Alcidion Group Limited (the "Company"). It does not purport to contain all the information that a prospective investor may require in connection with any potential investment in the Company. You should not treat the contents of this presen
Slide 4: Agenda
F ALCIDION AGENDA YA Contents Executive Summary 4 Market Opportunity 13 Product Overview 21 Customer Testimonials 29 Mgthan Buzza Questions 37 Executive Director Tel:+61 8 8208 4600 Mobile:+61 48886 2222 nathan.buzza@alcidion.com ve op DUCIDION
Slide 5: Executive Summary
For personal use only Executive Summary 4
Slide 6: For personal use only
ASX Ticker Market Capitalisation Management Ownership Share Price Cash on hand Enterprise Value Shares on Issue FY15 Revenues FY15 EBITDA Employees R&D Investment Prior Funding Performance Shares ALC ~$33.76m 39.55% Owned by Founders 8.65% Owned by Employees 5.60c $7.00m $26.76m 602,779,959 $5.05m,
Slide 7: For personal use only
• • • • For personal use only • • • • • • • • • • • • • 6
Slide 8: Executive Summary
JB accivion EXECUTIVE SUMMARY e Hospitals are built upon a complex eco-system of disparate Clinical Information Systems (CIS), e Alcidion’s Miya platform integrates disparate Clinical Information Systems to identify emerging clinical risk and push this clinical intelligence to the care team via a co
Slide 9: What is Miya?
F ALCIDION WHAT IS MIYA ? .Y e AnElectronic Health Software Platform that: — Consolidates clinical and administrative patient data ps y from multiple sources across the hospital (or & hospitals) into a single platform. — Identifies patient clinical risk and provides guidance to mitigate that risk. —
Slide 10: Global State of the Market
JB accivion GLOBAL STATE OF THE MARKET e Global expenditure on Healthcare IT is $USD40.4b, growing to $USD56.7b by 2017. e Mobile Health technology is growing from $USD6.9b market in 2014 to $USD23b market by 2017. e The Clinical Decision Support Systems Market is set to grow 21.5% CAGR from $USD1.1
Slide 11: For personal use only
“At BlueSky we meticulously evaluate every opportunity. Alcidion ticked all the boxes: Mobile, Healthcare, Information Technology, coupled with an internationally recognized Management Team.” Nick Dignam Investment Director Blue Sky Private Equity.
Slide 12: For personal use only
For personal use only 11
Slide 13: For personal use only
"the Miya platform is > creating a great deal of ) Interest. It's being used in hospitals across Australia and New Zealand, and there's a possibility it will be trialed here in South Australia soon.” Jay Weatherill MP Premier of South Australia
Slide 14: Market Opportunity
For personal use only Market Opportunity 13
Slide 15: Unique Opportunity To Be Part of the New Digital Health Economy
Unique Opportunity To Be Part of the New Digital Health Economy 7 The introduction of the Patient Protection & Affordable Care Act 2010 (“Obamacare”) requires US hospitals to adopt Electronic Medical Records or face a reduction in Medicare reimbursements.
Slide 16: For personal use only
“Capable and Experienced Management Team with a 7 strong track record of ) commercializing healthcare wi software, including the former CEO & Chairman of the South Australian Health Commission, a Stanford qualified Medical Doctor and a former Ernst & Young Entrepreneur of the Year.”
Slide 17: Proven Technology
Proven Technology Alcidion’s platform is installed into 11 large tertiary hospitals | | including Footscray, Sunshine, lL if! . Williamstown, Royal Darwin & I | Alice Springs Hospitals and | a" throughout Tasmania. See USe Only abit os med Wee SSSEe
Slide 18: Disruptive Technology Platform
5 cuits Disruptive Technology Platform a The platform is at the forefront of medical technology, on the crest of the next generation of healthcare technologies. f FOr personal u=
Slide 19: For personal use only
poaket oem The business recently secureda fe $1.75m contract with the Northern a Territory Health Department to roll out a pilot of the Computerised Physician Order Entry technology (CPOE). Several new contracts are presently being negotiated with leading public and private hospitals throughout Aust
Slide 20: For personal use only
The recent RTO of Naracoota Resources, will see the company fully funded, with in excess of $7.00m in cash and debt free.
Slide 21: EMR Adoption Model
JB accivion EMR ADOPTION MODEL EMR ADOPTION MODEL VU ve op DUCIDION
Slide 22: Product Overview
For personal use only Product Overview 21
Slide 23: Product Offering
JB accivion PRODUCT OFFERING Miya fae) Mize] Patient Flow Miya @lffatte d'a team based approach to managing clinical risk Create a safer, more efficient patient journey. Mitigate risks and streamline your Outpatient Department Results Electronic Department Referral Clinical Management Journey Boards
Slide 24: Alcidion's Miya Platform
$7? ALciDION ALCIDION’S MIYA PLATFORM 7 4 @ 2 ry © — wa # £ £ xo} < 5 ° te 5 Laboratory Results = ae Se = ih} Orders, Bookings & ‘= O Images Active Directory Roles, Users
Slide 25: Miya Overview
JB accivion MIYA OVERVIEW Restful APIs Miya Platform Intelligent EHR
Slide 26: For personal use only
For personal use only – – – – – 26
Slide 27: Miya Patient Flow
ve PRODUCT OVERVIEW o6 2-cbicn MIYA PATIENT FLOW e Miya Patient Flow guides the care team in optimising a patient's journey through the hospital services. e Miya Patient Flow supports the efficient use of hospital beds/resources whilst providing effective clinical outcomes for patients — it has appe
Slide 28: Miya Clinic
44 .Y PRODUCT OVERVIEW ALCIDION Miya Clinic provides clinical decision support for Doctors treating ambulatory patients in the Outpatient services of a hospital — Outpatient services include minor procedures, medical consultations/diagnosis and allied health interventions (e.g. physio). Australia’s
Slide 29: Customer Testimonials
For personal use only Customer Testimonials 29
Slide 30: For personal use only
“This has skyrocketed the efficiency in patient care as well as the safety” Professor Tissa Wijerante Consulting Neurologist Director of the Stroke & Neuroscience Unit Western Health
Slide 31: For personal use only
'“The system assists in safe and effective patient care by identifying patients who are at risk” ZO JF ad 4 Marcus Storey Nurse Unit Manager Western Health FOr personal u=
Slide 32: For personal use only
. “You'll see nearly all of the clinical, executive and divisional directors walking around with the bed management views on their iPads, and the same with the bed management staff, the quality managers, the NUMs and See any Staff that help move the patients around.” Jason Whakaari Executive Directo
Slide 33: For personal use only
“Rather than creating an electronic version of the existing patient journey boards, we have created an e-health guidance system."
Slide 34: For personal use only
For personal use only 37
Slide 35: Slides Unused
For personal use only Slides Unused 38
Slide 36: EMR adoption stages
For personal use only Stage Cumulative Capabilities 2015 2015 Q3 Final Stage 7 Complete EMR; CCD transactions to share data; Data 4.1% 4.2% warehousing; Data continuity with ED, ambulatory, OP Stage 6 Physician documentation (structured templates), full CDSS 25.4% 27.1% (variance & compliance), full
Slide 37: For personal use only
For personal use only • • • • • • • • • • 40
Slide 38: ASX Peer Group Comparison
+e ASX PEER GROUP COMPARISON con | Meet es ALCIDION GL@ BAL HEALTH Global Health $454m $1.23 $14.34m Uscom &% uscomLtd UCM $1.89m $1.13m $13.55m SG heath Resonance Health RHT $2.68m $260k $8.03m GQ ooestare Cosgate cas $1619m $2.83 $61.50m respi Respiri (iSonea) RSH Pre Revenue $6.07m $9.29m Analyti
Alcidion Group — Investor Presentation (February 2016) on 6ix